""GE's Prodigy series provides one of the most precise measures of bone density available today," said Hanson. "These successes demonstrate GE's technology and market leadership in bone densitometry and the company's commitment to finding new and more effective ways to help physicians diagnose osteoporosis and assess fracture risk."

According to Hanson more than two out of three bone density systems sold worldwide are manufactured by GE. The company is the industry leader in bone assessment technologies and has steadily grown its Lunar product line by continuing to provide what are widely considered to be the industry's most advanced technologies and services.


ABOUT GE HEALTHCARE
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

For more information about GE Healthcare, visit our website at www.gehealthcare.com.

Back to HCB News

More Industry Headlines